QQ客服 官方微博 反馈留言

浏览/检索结果: 共3条，第1-3条 帮助 限定条件 专题：上海药物研究所    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Pharmacokinetics and pharmacokinetic/pharmacodynamic relationship of vicagrel, a novel thienopyridine P2Y(12) inhibitor, compared with clopidogrel in healthy Chinese subjects following single oral dosing 期刊论文 EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 卷号: 127, 页码: 151-160 作者:  Li, Cai;  Zhang, Yifan;  Chen, Weili;  Lu, Youming;  Li, Wei 收藏  |  浏览/下载：103/0  |  提交时间：2019/01/08 Vicagrel  Clopidogrel  P2Y(12) inhibitor  Pharmacokinetics  Active metabolite  Thienopyridine   Evaluation of Tolerability, Pharmacokinetics and Pharmacodynamics of Vicagrel, a Novel P2Y12 Antagonist, in Healthy Chinese Volunteers 期刊论文 FRONTIERS IN PHARMACOLOGY, 2018, 卷号: 9 作者:  Li, Xiaojiao;  Liu, Ca;  Zhu, Xiaoxue;  Wei, Haijing;  Zhang, Hong 收藏  |  浏览/下载：59/0  |  提交时间：2019/01/08 vicagrel  pharmacokinetics  pharmacodynamics  safety  clopidogrel   Development and validation of a sensitive and rapid UHPLC-MS/MS method for the simultaneous quantification of the common active and inactive metabolites of vicagrel and clopidogrel in human plasma 期刊论文 JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2018, 卷号: 149, 页码: 394-402 作者:  Liu, Cai;  Lu, Youming;  Sun, Hongbin;  Yang, Jin;  Liu, Yongqiang 收藏  |  浏览/下载：32/0  |  提交时间：2019/01/08 Vicagrel  Clopidogrel  Active metabolite  LC-MS/MS  Human plasma  P2Y(12) inhibitor